Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Arun Koul"'
Publikováno v:
Annals of Indian Academy of Neurology, Vol 27, Iss 5, Pp 586-587 (2024)
Externí odkaz:
https://doaj.org/article/5f100206506b49c4b0636040ae295026
Autor:
Ganeshgouda Majigoudra, Ashish K Duggal, Debashish Chowdhury, Arun Koul, Vineet K Todi, Sujata Roshan
Publikováno v:
Annals of Indian Academy of Neurology, Vol 26, Iss 4, Pp 441-446 (2023)
Background: Myasthenia Gravis (MG) is a chronic fluctuating illness, due to the dysfunction of neuromuscular junction which is autoimmune in nature. The disease severely affects the Quality Of Life (QOL). Objective: The primary objective of our study
Externí odkaz:
https://doaj.org/article/065a0c67d86140198fce5c94cddb56d2
Autor:
Debashish Chowdhury, Ashwin K Panda, Ashutosh Gupta, Samiran Chowdhury, Ashish Duggal, Arun Koul
Publikováno v:
Annals of Indian Academy of Neurology, Vol 26, Iss 1, Pp 17-32 (2023)
Anti N-methyl D-aspartate receptor encephalitis (NMDAR-E) though rare, is currently considered as the commonest antibody mediated encephalitis in the world. No review on perspectives of NMDAR-E from India is available. The aim of the study was to rev
Externí odkaz:
https://doaj.org/article/65cb8169512f453985be7ef324141086
Publikováno v:
Cephalalgia Reports, Vol 1 (2018)
Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA) are rare primary headaches that can sometimes pre
Externí odkaz:
https://doaj.org/article/228c0d5622434b21a23b4c856838b03f
Autor:
Ashish Duggal, Anand Krishnan, Ankit Mundra, Debabrata Datta, Vaibhav Deorari, Arun Koul, Debashish Chowdhury, Apoorva Tomar
Publikováno v:
Acta Neurologica Scandinavica
OBJECTIVES: To assess the impact of lockdown during the COVID-19 pandemic on migraine patients in India on disease activity, healthcare accessibility, and quality of life (QoL). MATERIALS & METHODS: This internet-based survey study using a structured
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc89c357b3bcd99468551df4a54fa151
http://europepmc.org/articles/PMC8652819
http://europepmc.org/articles/PMC8652819
Publikováno v:
Cephalalgia : an international journal of headache. 42(9)
Objective To compare the efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block to topiramate monotherapy in adult chronic migraine patients. Background Options for the preventive treatment of chronic migra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::300d9710023d85efb1ecbfe615b70b77
https://pubmed.ncbi.nlm.nih.gov/35786012
https://pubmed.ncbi.nlm.nih.gov/35786012
Autor:
Debashish Chowdhury, AshwinK Panda, Ashutosh Gupta, Samiran Chowdhury, Ashish Duggal, Arun Koul
Publikováno v:
Annals of Indian Academy of Neurology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5a5002a7590fdffe6d8040e4383aaf6
https://doi.org/10.4103/aian.aian_519_22
https://doi.org/10.4103/aian.aian_519_22
Autor:
Debashish Chowdhury, Apoorva Tomar, Vaibhav Deorari, Ashish Duggal, Anand Krishnan, Arun Koul
Publikováno v:
Cephalalgia. 43:033310242211435
Background Greater occipital nerve blockade for the prevention of chronic migraine has a limited evidence base. A robust randomized double-blind, placebo-controlled trial is needed. Methods This double-blind, placebo-controlled, parallel-group trial,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e723f7e073c87b7974e035150934358
https://doi.org/10.1177/03331024221143541
https://doi.org/10.1177/03331024221143541
Autor:
Arun Koul, Debabrata Datta, Anu Gupta, Luv Bansal, Debashish Chowdhury, Ashish Duggal, Anand Krishnan, Ankit Mundra
Publikováno v:
Cephalalgia : an international journal of headache. 42(4-5)
Objective The aim of the TOP-PRO-study, a double-blind randomized controlled trial, was to assess the efficacy (non-inferiority) and tolerability of propranolol compared to topiramate for the prevention of chronic migraine. Background Except for topi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f01be4011babf2199e8fbe88a2d3d2
https://pubmed.ncbi.nlm.nih.gov/34579560
https://pubmed.ncbi.nlm.nih.gov/34579560
Autor:
Debabrata Datta, Debashish Chowdhury, Anu Gupta, Arun Koul, Ankit Mundra, Luv Bansal, Ashish Duggal, Anand Krishnan
Publikováno v:
Journal of the Neurological Sciences. 429:119305
Background and aims: We conducted TOP-PRO-study, a double-blind RCT, to know whether propranolol is as efficacious as topiramate for the prevention of CM. In this paper, we report the secondary efficacy outcomes. Primary efficacy outcome showing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd3e7ea585ff6d9d5d91a1f46c68449e
https://doi.org/10.1016/j.jns.2021.119305
https://doi.org/10.1016/j.jns.2021.119305